191 related articles for article (PubMed ID: 14720037)
1. Current status of gene therapy for cystic fibrosis pulmonary disease.
Kennedy MJ
Am J Respir Med; 2002; 1(5):349-60. PubMed ID: 14720037
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy in cystic fibrosis.
Flotte TR; Laube BL
Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
[TBL] [Abstract][Full Text] [Related]
3. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
[TBL] [Abstract][Full Text] [Related]
4. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
[TBL] [Abstract][Full Text] [Related]
5. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
Knowles MR; Hohneker KW; Zhou Z; Olsen JC; Noah TL; Hu PC; Leigh MW; Engelhardt JF; Edwards LJ; Jones KR
N Engl J Med; 1995 Sep; 333(13):823-31. PubMed ID: 7544439
[TBL] [Abstract][Full Text] [Related]
6. [On the way to gene therapy in cystic fibrosis].
Norek A; Bal J
Med Wieku Rozwoj; 2006; 10(1 Pt 2):247-74. PubMed ID: 17028392
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
[TBL] [Abstract][Full Text] [Related]
8. Ability of adenovirus vectors containing different CFTR transcriptional cassettes to correct ion transport defects in CF cells.
Jiang C; O'Connor SP; Armentano D; Berthelette PB; Schiavi SC; Jefferson DM; Smith AE; Wadsworth SC; Cheng SH
Am J Physiol; 1996 Oct; 271(4 Pt 1):L527-37. PubMed ID: 8897899
[TBL] [Abstract][Full Text] [Related]
9. Airway epithelium directed gene therapy for cystic fibrosis.
White AF; Ponnazhagan S
Med Chem; 2006 Sep; 2(5):499-503. PubMed ID: 17017989
[TBL] [Abstract][Full Text] [Related]
10. Is gene therapy in cystic fibrosis a realistic expectation?
McElvaney NG
Curr Opin Pulm Med; 1996 Nov; 2(6):466-71. PubMed ID: 9363187
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease.
Marquez Loza LI; Yuen EC; McCray PB
Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30875857
[TBL] [Abstract][Full Text] [Related]
12. Non-viral approach toward gene therapy of cystic fibrosis lung disease.
Bragonzi A; Conese M
Curr Gene Ther; 2002 Sep; 2(3):295-305. PubMed ID: 12189717
[TBL] [Abstract][Full Text] [Related]
13. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.
Yei S; Mittereder N; Wert S; Whitsett JA; Wilmott RW; Trapnell BC
Hum Gene Ther; 1994 Jun; 5(6):731-44. PubMed ID: 7948135
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for cystic fibrosis lung disease: current status and future perspectives.
Rosenecker J; Huth S; Rudolph C
Curr Opin Mol Ther; 2006 Oct; 8(5):439-45. PubMed ID: 17078386
[TBL] [Abstract][Full Text] [Related]
15. Toward cystic fibrosis gene therapy.
Wagner JA; Gardner P
Annu Rev Med; 1997; 48():203-16. PubMed ID: 9046956
[TBL] [Abstract][Full Text] [Related]
16. Emerging gene therapies for cystic fibrosis.
Miah KM; Hyde SC; Gill DR
Expert Rev Respir Med; 2019 Aug; 13(8):709-725. PubMed ID: 31215818
[No Abstract] [Full Text] [Related]
17. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
[TBL] [Abstract][Full Text] [Related]
18. Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.
Flotte TR
Curr Opin Mol Ther; 2001 Oct; 3(5):497-502. PubMed ID: 11699895
[TBL] [Abstract][Full Text] [Related]
19. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.
Flotte TR; Zeitlin PL; Reynolds TC; Heald AE; Pedersen P; Beck S; Conrad CK; Brass-Ernst L; Humphries M; Sullivan K; Wetzel R; Taylor G; Carter BJ; Guggino WB
Hum Gene Ther; 2003 Jul; 14(11):1079-88. PubMed ID: 12885347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]